Teva Pharmaceutical Industries competitive analysis

Explore patent oppositions filed by Teva Pharmaceutical Industries against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Mar 26, 2026
Patent NumberTitleApplicantOpposition Date
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 21, 2025
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISOct 29, 2025
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSSep 4, 2025
Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry DiseaseAMICUS THERAPEUTICSSep 4, 2025
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 22, 2025
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025

Explore Teva Pharmaceutical Industries's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Mar 26, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 13, 2024Medical Injection Device Packaging2
Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2

Latest PTAB cases involving Teva Pharmaceutical Industries

Discover the latest PTAB cases involving Teva Pharmaceutical Industries, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teva Pharmaceutical Industries with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Mar 26, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEVA PHARMACEUTICALS211171712
BIOGEN MA - 52 - 7
BOEHRINGER INGELHEIM49181109
NOVARTIS6441 - 21